142 related articles for article (PubMed ID: 38593443)
1. Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder in women.
Zhang E; Virk ZM; Rodriguez-Lopez J; Al-Samkari H
Blood Adv; 2024 Jun; 8(12):3166-3172. PubMed ID: 38593443
[TBL] [Abstract][Full Text] [Related]
2. [Bevacizumab: a new success in hereditary hemorrhagic telangiectasia].
Bennesser Alaoui H; Lehraiki M; Hamaz S; El Attar N; Fakhreddine N; Serraj K
Rev Med Interne; 2015 Sep; 36(9):623-5. PubMed ID: 25595875
[TBL] [Abstract][Full Text] [Related]
3. Hereditary hemorrhagic telangiectasia (HHT): a practical guide to management.
Hammill AM; Wusik K; Kasthuri RS
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):469-477. PubMed ID: 34889398
[TBL] [Abstract][Full Text] [Related]
4. Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia.
Parambil JG; Gossage JR; McCrae KR; Woodard TD; Menon KVN; Timmerman KL; Pederson DP; Sprecher DL; Al-Samkari H
Angiogenesis; 2022 Feb; 25(1):87-97. PubMed ID: 34292451
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the relationship of von Willebrand disease (vWD) and hereditary hemorrhagic telangiectasia and identification of a potential type IIA vWD mutation (IIe865 to Thr).
Iannuzzi MC; Hidaka N; Boehnke M; Bruck ME; Hanna WT; Collins FS; Ginsburg D
Am J Hum Genet; 1991 Apr; 48(4):757-63. PubMed ID: 1673047
[TBL] [Abstract][Full Text] [Related]
6. High Rates of Bleeding Complications among Hospitalized Patients with Hereditary Hemorrhagic Telangiectasia in the United States.
Brinjikji W; Wood CP; Lanzino G; Cloft HJ; Misra S; Kallmes DF; Kamath P; Pruthi RK; Krowka MJ; Swanson KL; Iyer VN
Ann Am Thorac Soc; 2016 Sep; 13(9):1505-11. PubMed ID: 27387823
[TBL] [Abstract][Full Text] [Related]
7. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders.
Sidonio RF; Bryant PC; Di Paola J; Hale S; Heiman M; Horowitz GS; Humphrey C; Jaffray J; Joyner LC; Kasthuri R; Konkle BA; Kouides PA; Montgomery R; Neeves K; Randi AM; Scappe N; Tarango C; Tickle K; Trapane P; Wang M; Waters B; Flood VH
Expert Rev Hematol; 2023 Mar; 16(sup1):39-54. PubMed ID: 36920856
[TBL] [Abstract][Full Text] [Related]
8. Gender differences in hereditary hemorrhagic telangiectasia severity.
Mora-Luján JM; Iriarte A; Alba E; Sánchez-Corral MA; Cerdà P; Cruellas F; Ordi Q; Corbella X; Ribas J; Castellote J; Riera-Mestre A
Orphanet J Rare Dis; 2020 Mar; 15(1):63. PubMed ID: 32122373
[TBL] [Abstract][Full Text] [Related]
9. Integration of clinical parameters, genotype and epistaxis severity score to guide treatment for hereditary hemorrhagic telangiectasia associated bleeding.
Beckman JD; Li Q; Hester ST; Leitner O; Smith KL; Kasthuri RS
Orphanet J Rare Dis; 2020 Jul; 15(1):185. PubMed ID: 32660636
[TBL] [Abstract][Full Text] [Related]
10. Hereditary hemorrhagic telangiectasia: a rare cause of severe anemia.
dos Santos JW; Dalcin TC; Neves KR; Mann KC; Pretto GL; Bertolazi AN
J Bras Pneumol; 2007; 33(1):109-12. PubMed ID: 17568877
[TBL] [Abstract][Full Text] [Related]
11. Complications and mortality in hereditary hemorrhagic telangiectasia: A population-based study.
Donaldson JW; McKeever TM; Hall IP; Hubbard RB; Fogarty AW
Neurology; 2015 May; 84(18):1886-93. PubMed ID: 25862798
[TBL] [Abstract][Full Text] [Related]
12. Hereditary hemorrhagic telangiectasia in a 42-year-old Ethiopian man presenting with severe anemia and high-output heart failure: A case report with literature review.
Solela G; Adamseged M; Mohammed A
Clin Case Rep; 2023 Jul; 11(7):e7694. PubMed ID: 37448947
[TBL] [Abstract][Full Text] [Related]
13. Understanding hereditary hemorrhagic telangiectasia: From genetic anomalies to systemic manifestations, quality of life, and epistaxis management-Exploring the otolaryngologist's integral role.
Hayama M; Maeda Y; Obata S; Tsuda T; Takeda K; Nishida T; Inohara H
Auris Nasus Larynx; 2024 Apr; 51(2):305-312. PubMed ID: 38008660
[TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia.
Thompson KP; Sykes J; Chandakkar P; Marambaud P; Vozoris NT; Marchuk DA; Faughnan ME
Orphanet J Rare Dis; 2022 Nov; 17(1):405. PubMed ID: 36344987
[TBL] [Abstract][Full Text] [Related]
15. Epistaxis in hereditary haemorrhagic telangiectasia.
Haitjema T; Balder W; Disch FJ; Westermann CJ
Rhinology; 1996 Sep; 34(3):176-8. PubMed ID: 8938889
[TBL] [Abstract][Full Text] [Related]
16. Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia.
Faughnan ME; Mager JJ; Hetts SW; Palda VA; Lang-Robertson K; Buscarini E; Deslandres E; Kasthuri RS; Lausman A; Poetker D; Ratjen F; Chesnutt MS; Clancy M; Whitehead KJ; Al-Samkari H; Chakinala M; Conrad M; Cortes D; Crocione C; Darling J; de Gussem E; Derksen C; Dupuis-Girod S; Foy P; Geisthoff U; Gossage JR; Hammill A; Heimdal K; Henderson K; Iyer VN; Kjeldsen AD; Komiyama M; Korenblatt K; McDonald J; McMahon J; McWilliams J; Meek ME; Mei-Zahav M; Olitsky S; Palmer S; Pantalone R; Piccirillo JF; Plahn B; Porteous MEM; Post MC; Radovanovic I; Rochon PJ; Rodriguez-Lopez J; Sabba C; Serra M; Shovlin C; Sprecher D; White AJ; Winship I; Zarrabeitia R
Ann Intern Med; 2020 Dec; 173(12):989-1001. PubMed ID: 32894695
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Timolol in a Novel Intranasal Thermosensitive Gel for Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis: A Randomized Clinical Trial.
Peterson AM; Lee JJ; Kallogjeri D; Schneider JS; Chakinala MM; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1006-1014. PubMed ID: 32940653
[TBL] [Abstract][Full Text] [Related]
18. Pazopanib effective for bevacizumab-unresponsive epistaxis in hereditary hemorrhagic telangiectasia.
Parambil JG; Woodard TD; Koc ON
Laryngoscope; 2018 Oct; 128(10):2234-2236. PubMed ID: 29451965
[TBL] [Abstract][Full Text] [Related]
19. Iron deficiency anemia related to hereditary hemorrhagic telangiectasia: response to treatment with bevacizumab.
Fleagle JM; Bobba RK; Kardinal CG; Freter CE
Am J Med Sci; 2012 Mar; 343(3):249-51. PubMed ID: 22227516
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
